185 related articles for article (PubMed ID: 35993319)
1. Efficacy and acceptability of second-generation antipsychotics with antidepressants in unipolar depression augmentation: a systematic review and network meta-analysis.
Yan Y; Yang X; Wang M; Chen B; Yin L; Ma X
Psychol Med; 2022 Sep; 52(12):2224-2231. PubMed ID: 35993319
[TBL] [Abstract][Full Text] [Related]
2. Second-generation antipsychotics for major depressive disorder and dysthymia.
Komossa K; Depping AM; Gaudchau A; Kissling W; Leucht S
Cochrane Database Syst Rev; 2010 Dec; (12):CD008121. PubMed ID: 21154393
[TBL] [Abstract][Full Text] [Related]
3. Comparative Outcomes of Commonly Used Off-Label Atypical Antipsychotics in the Treatment of Dementia-Related Psychosis: A Network Meta-analysis.
Yunusa I; Rashid N; Demos GN; Mahadik BS; Abler VC; Rajagopalan K
Adv Ther; 2022 May; 39(5):1993-2008. PubMed ID: 35247186
[TBL] [Abstract][Full Text] [Related]
4. Efficacy and safety/tolerability of antipsychotics in the treatment of adult patients with major depressive disorder: a systematic review and meta-analysis.
Kishimoto T; Hagi K; Kurokawa S; Kane JM; Correll CU
Psychol Med; 2023 Jul; 53(9):4064-4082. PubMed ID: 35510505
[TBL] [Abstract][Full Text] [Related]
5. Augmentation strategies for treatment resistant major depression: A systematic review and network meta-analysis.
Nuñez NA; Joseph B; Pahwa M; Kumar R; Resendez MG; Prokop LJ; Veldic M; Seshadri A; Biernacka JM; Frye MA; Wang Z; Singh B
J Affect Disord; 2022 Apr; 302():385-400. PubMed ID: 34986373
[TBL] [Abstract][Full Text] [Related]
6. Comparative efficacy, acceptability, and tolerability of augmentation agents in treatment-resistant depression: systematic review and network meta-analysis.
Zhou X; Ravindran AV; Qin B; Del Giovane C; Li Q; Bauer M; Liu Y; Fang Y; da Silva T; Zhang Y; Fang L; Wang X; Xie P
J Clin Psychiatry; 2015 Apr; 76(4):e487-98. PubMed ID: 25919841
[TBL] [Abstract][Full Text] [Related]
7. Pharmacological treatment for bipolar mania: a systematic review and network meta-analysis of double-blind randomized controlled trials.
Kishi T; Ikuta T; Matsuda Y; Sakuma K; Okuya M; Nomura I; Hatano M; Iwata N
Mol Psychiatry; 2022 Feb; 27(2):1136-1144. PubMed ID: 34642461
[TBL] [Abstract][Full Text] [Related]
8. Comparative efficacy and acceptability of 21 antidepressant drugs for the acute treatment of adults with major depressive disorder: a systematic review and network meta-analysis.
Cipriani A; Furukawa TA; Salanti G; Chaimani A; Atkinson LZ; Ogawa Y; Leucht S; Ruhe HG; Turner EH; Higgins JPT; Egger M; Takeshima N; Hayasaka Y; Imai H; Shinohara K; Tajika A; Ioannidis JPA; Geddes JR
Lancet; 2018 Apr; 391(10128):1357-1366. PubMed ID: 29477251
[TBL] [Abstract][Full Text] [Related]
9. Lurasidone compared to other atypical antipsychotic monotherapies for bipolar depression: A systematic review and network meta-analysis.
Ostacher M; Ng-Mak D; Patel P; Ntais D; Schlueter M; Loebel A
World J Biol Psychiatry; 2018 Dec; 19(8):586-601. PubMed ID: 28264635
[TBL] [Abstract][Full Text] [Related]
10. Efficacy and tolerability of atypical antipsychotics for acute bipolar depression: a network meta-analysis.
Kadakia A; Dembek C; Heller V; Singh R; Uyei J; Hagi K; Nosaka T; Loebel A
BMC Psychiatry; 2021 May; 21(1):249. PubMed ID: 33975574
[TBL] [Abstract][Full Text] [Related]
11. Augmentation of antidepressants with atypical antipsychotics: a review of the current literature.
Philip NS; Carpenter LL; Tyrka AR; Price LH
J Psychiatr Pract; 2008 Jan; 14(1):34-44. PubMed ID: 18212601
[TBL] [Abstract][Full Text] [Related]
12. Lurasidone compared to other atypical antipsychotic monotherapies for adolescent schizophrenia: a systematic literature review and network meta-analysis.
Arango C; Ng-Mak D; Finn E; Byrne A; Loebel A
Eur Child Adolesc Psychiatry; 2020 Sep; 29(9):1195-1205. PubMed ID: 31758359
[TBL] [Abstract][Full Text] [Related]
13. Comparative efficacy and tolerability of pharmacological treatments for the treatment of acute bipolar depression: A systematic review and network meta-analysis.
Bahji A; Ermacora D; Stephenson C; Hawken ER; Vazquez G
J Affect Disord; 2020 May; 269():154-184. PubMed ID: 32339131
[TBL] [Abstract][Full Text] [Related]
14. Pharmacotherapy for Treatment-Resistant Depression: Antidepressants and Atypical Antipsychotics.
Vas C; Jain A; Trivedi M; Jha MK; Mathew SJ
Psychiatr Clin North Am; 2023 Jun; 46(2):261-275. PubMed ID: 37149344
[TBL] [Abstract][Full Text] [Related]
15. [Augmentation of antidepressants with atypical antipsychotics in non-delusional unipolar depressed patients with non-response to antidepressant-monotherapy].
Erbe S; Gutwinski S; Bschor T
Psychiatr Prax; 2012 Mar; 39(2):57-63. PubMed ID: 22189902
[TBL] [Abstract][Full Text] [Related]
16. Meta-analysis on the efficacy and tolerability of the augmentation of antidepressants with atypical antipsychotics in patients with major depressive disorder.
Wen XJ; Wang LM; Liu ZL; Huang A; Liu YY; Hu JY
Braz J Med Biol Res; 2014 Jul; 47(7):605-16. PubMed ID: 24919175
[TBL] [Abstract][Full Text] [Related]
17. Efficacy and Tolerability of Combination Treatments for Major Depression: Antidepressants plus Second-Generation Antipsychotics vs. Esketamine vs. Lithium.
Vázquez GH; Bahji A; Undurraga J; Tondo L; Baldessarini RJ
J Psychopharmacol; 2021 Aug; 35(8):890-900. PubMed ID: 34238049
[TBL] [Abstract][Full Text] [Related]
18. Second-generation antipsychotics for anxiety disorders.
Depping AM; Komossa K; Kissling W; Leucht S
Cochrane Database Syst Rev; 2010 Dec; (12):CD008120. PubMed ID: 21154392
[TBL] [Abstract][Full Text] [Related]
19. Second-generation antipsychotics in major depressive disorder: update and clinical perspective.
Chen J; Gao K; Kemp DE
Curr Opin Psychiatry; 2011 Jan; 24(1):10-7. PubMed ID: 21088586
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
